Focal cerebral ischemia may occur in the presence of a normal or elevated SjvO 2 if the involved area of the brain is small or if the reduced oxygen saturation from the ischemic brain is offset by a high oxygen saturation from surrounding hyperemic brain. Dysoxia (defined as oxygen-limited cytochrome turnover) 7, 23 and/or restricted oxygen diffusion from the erythrocytes to the mitochondria can also result in a normal or elevated SjvO 2 . In some cases, measured values of cerebral oxygen extraction and CMRO 2 do not accurately reflect neural metabolic demands, and cerebral ischemic damage could occur despite a superabundant supply of oxygen to the brain. Although oxygen delivery and oxygen consumption are measurable, the true metabolic requirements of the cells, the "oxygen demand," cannot be determined.
The anatomy of the jugular venous system may also play a role in generating high SjvO 2 values. The internal jugular vein chosen for monitoring (right or left) may affect the values obtained for SjvO 2 . 27 More important, when CBF is globally low, extracerebral contamination of blood in the jugular bulb may be significant and may contribute to an increase in the value obtained for SjvO 2 . Rapid drawing of the blood sample through the catheter (rates Ͼ 2 ml/minute) has been another source of artifactual increases in SjvO 2 . 16 The purpose of this study was to investigate the incidence of SjvO 2 values above the upper limit of normal (≥ 75%) in severely head injured patients and to relate these elevated values to measurements of global CBF and metabolism and also to clinical outcome.
Clinical Material and Methods

Patient Characteristics
This study was approved by the Baylor Affiliates Review Board for Human Subject Research, and informed consent for participation was obtained from the patients' family members. Data on CBF and cerebral metabolic rates were gathered from 465 severely head injured patients admitted to the Neurosurgical Intensive Care Unit of Ben Taub General Hospital between 1986 and 1997. Their levels of consciousness were seriously impaired: these patients were either not obeying commands on admission or deteriorated to this level after admission. All patients were managed by a standard protocol that emphasized prompt evacuation of intracranial hematomas and prevention of secondary insults to the brain. Intracranial pressure (ICP) was continuously monitored using a ventriculostomy, a parenchymal microtransducer, or a fiberoptic monitor. Data from periods when the patients were treated with pentobarbital coma for refractory intracranial hypertension were excluded from the analysis. This resulted in total exclusion of 15 patients from the study because no measurements of CBF prior to receiving barbiturates were available for them and also resulted in exclusion of segments of data from 67 of the remaining 450 patients.
Physiological Parameters
By using an oximeter (IL-284 CO-Oximeter; Instrumentation Laboratory, Lexington, MA), SjvO 2 was determined from blood samples drawn through an indwelling catheter positioned in the jugular bulb. In the first 102 patients, the catheter was placed on the side of the worst injury or on the right side if the injury was diffuse. In the remaining patients, the catheter was placed on the side of the larger internal jugular vein. Blood samples were obtained at least every 8 to 24 hours to calibrate a concomitantly placed fiberoptic oxygen saturation catheter (No. 4 French catheter; Abbott Laboratories, North Chicago, IL) that measured SjvO 2 continuously. Samples were also obtained in the event of jugular venous desaturation. The SjvO 2 data analyzed in this report were all obtained from the oximeter and not the catheter.
Glucose and lactate concentrations were measured using a stat-Plus analyzer (YSI 2300; Yellow Springs Instruments, Yellow Springs, OH). Global CBF was estimated using the Kety-Schmidt method with N 2 O as a tracer. The CMRO 2 and cerebral metabolic rates of glucose (CMRG) and lactate (CMRL) were calculated from the product of the CBF and the arteriovenous difference of oxygen (AVDO 2 ), glucose (AVDG), and lactate (AVDL), respectively. The lactate/glucose index (LGI) was calculated using the following formula: (AVDL) ϫ 100%/ (AVDG ϫ 2). The LGI is used to estimate the percentage of total glucose that is metabolized anaerobically to the end-product lactate and is normally less than 5%. 5 Cerebrovascular resistance (CVR) values were obtained by dividing cerebral perfusion pressure (CPP) by CBF.
Classification of Groups
High SjvO 2 (Group I) was defined as 75% or higher, normal SjvO 2 (Group II) as 56 to 74%, and low SjvO 2 (Group III) as 55% or lower. These categories refer to the mean SjvO 2 for the entire period of monitoring for each patient.
Outcome at 6 months was assessed using the Glasgow Outcome Scale (GOS). 11 Outcomes were classified into three groups: 1) dead or persistent vegetative state; 2) severe disability; and 3) moderate disability or good recovery. When a 6-month outcome was not available, the outcome at the last known contact (usually 3 months) was used.
Statistical Analysis
All summary data are expressed as the mean Ϯ standard deviation or median (25th and 75th percentiles). For the summary data, the average of variables from the entire period of monitoring was calculated for each patient.
The distributions of the cerebral hemodynamic/metabolic variables are shown in the figures as box plots. The horizontal line across the box marks the median, and the lower and upper ends of box indicate the 25th and 75th percentiles. The error bars mark the 10th and 90th percentiles.
The median values of the physiological measurements were compared by analysis of variance on ranks, followed by Dunn's test when multiple comparisons were made. Differences in proportions were analyzed using the chisquare test.
Results
Demographic Characteristics
The 450 patients studied had a median age (25th and 75th percentiles) of 30 years (range 23-41 years) and a median Glasgow Coma Scale 28 (GCS) score of 7 (range 4-8) on the 1st day postinjury. Eighty-six percent of the patients were men. Eighty-nine percent of the patients presented with a closed head injury (diffuse brain injury 24.6%, contusion or intracerebral hematoma 29.8%, subdural hematoma 28%, and epidural hematoma 6.7%). A penetrating injury was present in the other 11%. At 6 months postinjury, a good recovery or moderate disability had been achieved in 42% of patients, severe disability was present in 24.4%, and 33.6% remained in a vegetative state or were dead.
Distribution of SjvO 2 Measurements
In the 450 patients 2977 individual measurements of CBF and cerebral metabolism were made (average of 6.6 measurements per patient) during Days 1 to 10 postinjury. The average SjvO 2 for each patient was calculated from these individual values. Figure 1 upper illustrates the distribution of these average SjvO 2 values for the 450 patients, and the limits that were used to divide the patients into Groups I, II, or III. Elevated mean values for SjvO 2 were seen in 86 (19.1%) of 450 patients, 342 (76%) had a normal SjvO 2 , and 22 (4.9%) had a low SjvO 2 .
The distribution of the individual measurements of SjvO 2 was similar ( Fig. 1 lower) . Of the 2977 individual measurements of SjvO 2 , 830 (28%) were 75% or higher, 1875 (63%) were between 56% and 74%, and 272 (9%) were 55% or lower. Figure 2 shows the change in the distribution of the 
Characteristics of the Three Groups
The demographic characteristics of the three SjvO 2 groups are summarized in Fig. 3 left. Age, admission GCS score, and type of injury were similar in the three groups of patients. There were no significant differences in the ICP, mean arterial pressure, or CPP (Fig. 4 left) , and hemoglobin concentration and PaCO 2 did not differ significantly among the groups.
The neurological outcome, however, was strikingly different in the three groups. Patients in both Groups I and III had significantly higher mortality rates, and there were smaller numbers of patients with favorable outcomes than in Group II ( Table 1 ). The outcome was not significantly different between Groups I and III (p = 0.103).
The most important additional differences among the three groups were in the cerebral hemodynamic and metabolic variables (Figs. 5 and 6 left). The hemodynamic picture of patients in Group II was typical of severely head injured patients, with a CMRO 2 , CMRG, and GMRL that were lower than normal, a normal CBF and CVR, and a lower than normal AVDO 2 , AVDG, and AVDL. Values in Groups I and III varied significantly from this typical head injury pattern.
In Group I we found a higher CBF, CMRL, and LGI, and a lower CVR, CMRO 2 , and AVDO 2 than in Group II. Patients in this group also tended to have a lower CMRG and a higher AVDL than those in Group II, but the differences were not significant when adjusted for multiple comparisons. The patients in Group III, in contrast, had a lower CBF and a higher AVDO 2 Group II. The CMRO 2 , CMRG, and CMRL values were not significantly different in Groups II and III.
Relationship of CBF and Cerebral Metabolic Parameters to Outcome
Outcome in All Patients. The relationship of outcome to the demographic characteristics and the CBF and cerebral metabolic variables are shown in Figs. 3 to 6 right. The patients who recovered to a GOS score of good recovery or moderate disability were younger and had a higher admission GCS score than the patients who died or became vegetative. Gender distribution and type of injury were not significantly different among the outcome groups. The patients who attained a favorable outcome also demonstrated a higher CMRO 2 than those who were severely disabled and those who died or became vegetative. They had a lower ICP than the patients who died or became vegetative, and a lower mean arterial blood pressure and CVR than the patients who recovered with a severe disability. The CBF tended to be higher in the patients who had a good outcome, but the difference was not quite statistically significant (p = 0.085).
Outcome in Group I. Twenty-two (25.6%) of the patients in Group I had a favorable outcome, defined as a good recovery or moderate disability. Twenty-two (25.6%) recovered with a severe disability. Forty-two (48.8%) died or entered a persistent vegetative state. As illustrated in Figs. 3 to 6 right, there were significant differences in the demographic and cerebral hemodynamic/metabolic characteristics among these outcome groups.
The patients in Group I who had a favorable outcome were younger than the patients who were severely disabled and those who died or became vegetative. The patients in Group I with a favorable outcome had more diffuse injuries, and more intracranial hematomas were found in patients with a severe disability and those who died or became vegetative. The patients with a favorable outcome had a lower ICP than those who died or became vegetative. The patients in Group I who had a favorable outcome tended to have a higher CBF and a lower CVR than the patients who had an unfavorable outcome. The patients in whom a favorable outcome was achieved had a significantly higher CMRO 2 and a significantly greater cerebral lactate production than the patients in Group I who became vegetative or died.
Discussion
Monitoring of SjvO 2 is commonly used to judge the adequacy of cerebral oxygenation because it provides an assessment of the overall balance between cerebral metabolism and CBF. A greater than normal SjvO 2 is often interpreted as indicating that the CBF is more than adequate to satisfy cerebral metabolic requirements. This study raises the possibility that, in many cases, this interpretation may be incorrect and that an elevated SjvO 2 should not be automatically equated with hyperemia. Instead, as diagrammed in Fig. 7 , an elevated SjvO 2 appears to be a heterogeneous condition. If the cause of the high SjvO 2 is primarily an increase in CBF and not a major decrease in CMRO 2 , the outcome is generally favorable. Patients with these symptoms are often young and have a less severe head injury with mild, if any, intracranial hypertension. However, if the cause of the high SjvO 2 is a decrease in the CMRO 2 , especially to Ͻ 1.5 ml/100 g/minute, the outcome is usually poor. The cause of the reduced CMRO 2 is either an alteration in cerebral oxygen extraction capabilities or the presence of ischemic regions in the brain. Patients with such symptoms are often older and have severe intracranial hypertension.
Comparison With Other Studies of SjvO 2 and CBF
On the surface, the data reported here may seem to conflict with previously published studies. Most of these apparent conflicts arise because an elevated SjvO 2 cannot always be equated with an elevated CBF.
Our data demonstrated a significantly worse outcome in patients who had an elevated SjvO 2 , whereas many previous studies have emphasized a worse outcome in patients in whom a reduced CBF and episodes of reduced SjvO 2 were found. 9, 13, 20 This difference probably stems from the fact that a high SjvO 2 did not always indicate an elevated CBF. A reduced CMRO 2 was more commonly the cause of the high SjvO 2 . In the previous studies, CMRO 2 was an important covariate in the relationship between CBF and outcome, and within each CBF level (low, normal, elevated), there was a demonstrable impairment in outcome following decreases in CMRO 2 . 21 We observed no correlation between CBF and SjvO 2 . In another study a significant nonlinear relationship has been shown between CBF and AVDO 2 and between CBF and SjvO 2 .
20 However, this relationship was only present when patients with increased cerebral lactate production were excluded. When all patients were examined, the same poor relationship between CBF and AVDO 2 and between CBF and SjvO 2 was observed.
Our data indicated that, as a group, patients with a high SjvO 2 have a lower CMRO 2 than patients with a normal or low SjvO 2 . In other studies, a high CBF has been associated with a relatively higher CMRO 2 . 20 This difference is probably seen because SjvO 2 can be elevated because of a high CBF or because of a low CMRO 2 , and in most of the cases in the present series a high SjvO 2 was associated with a low CMRO 2 .
We found that there was no difference in ICP among the three SjvO 2 groups; within Group I, ICP was significantly higher only in the patients who died. This same pattern was observed in the entire group of 450 patients. Some investigators have reported a higher incidence of intracranial hypertension in patients who have an elevated CBF. 12, 19 Other investigators have not found a significant relationship between intracranial hypertension and the level of CBF. 18, 20 In many other respects, our data are entirely consistent with previous reports. We found that a reduced CBF and SjvO 2 were most common during the first 24 hours postinjury. An elevated SjvO 2 was more common after the 1st day. These data are consistent with previous work showing that hyperemia commonly occurs in the days following head injury, 19 and they are also consistent with those reported in other studies of CBF early after injury.
2,3 Martin, et al., 15 also described a characteristic CBF pattern of initial hypoperfusion followed by a period of hyperemia and then a period of vasospasm after head injury.
An SjvO 2 of 75% or higher was not always related to an adequate cerebral perfusion. In fact, elevated SjvO 2 was associated with a very wide range of CBF and CPP values. The CPP and/or CBF values that were normal or even elevated were by themselves insufficient to guarantee the adequacy of cerebral oxygen metabolism. It has been shown that cerebral hemodynamic and metabolic variables in traumatic brain injury do not necessarily correlate with CPP. In a porcine model of cryogenic brain injury, Zhuang, et al., 30 found persistent posttraumatic ischemia despite normalization of CPP. They proposed a significant increase in CVR as the cause of the ischemia.
A relationship between clinical condition, CMRO 2 , and outcome after traumatic coma has been noted by several authors. 10, [17] [18] [19] 26 Shalit, et al., 26 found that CMRO 2 values below 1.4 ml/100 g/minute during coma were incompatible with recovery of consciousness. In the series of Roquefeuil, et al., 24 the lowest CMRO 2 value consistent with recovery was 1.5 ml/100 g/minute. Jaggi, et al., 10 reported that AVDO 2 values obtained during the 1st week postinjury were indicative of hyperemia significantly more often in patients who died or remained vegetative than in the group with a 6-month outcome of severe disability, moderate disability, or good recovery. Yukota er levels of coma (except for patients with a GCS score of 3), indicating uncoupling of CBF and metabolism beginning on the 1st day postinjury. In a recent study, Cruz 8 found higher mortality rates in patients who had an initial decrease in cerebral oxygen extraction and suggested that an initial increase in oxygen extraction was indicative of neuronal viability in patients with traumatic diffuse swelling. Robertson, et al., 22 measured CMRO 2 and CBF in 44 comatose head-injured patients to determine if metabolic changes could be used to identify the patients who would develop cerebral infarction. A CMRO 2 of less than 1.3 ml/100 g/minute was rare in patients who had no ischemic injury but occurred at some time in all patients who developed an infarction.
Implications for Management
Determining the adequacy of cerebral perfusion in individual comatose patients remains difficult. Defining ischemia only in terms of CBF and oxygen supply overlooks the importance of the functional state of the tissue. These results may have some important implications for the management of head-injured patients. Posttraumatic alterations in CBF are often heterogeneous. Regional CBF may be simultaneously increased in some parts of the brain and decreased in others. It is therefore possible that attempts to control elevated ICP by maneuvers that globally reduce CBF might actually produce focal areas of relative ischemia. Unless patients are adequately monitored, significant potential hazards may accompany such therapies as vasoconstrictor administration and profound hyperventilation. 6, 14 In some cases, the SjvO 2 may appear normal although brain parenchyma are actually suffering from hypoperfusion, in which case augmentation of an already supranormal CBF may be required. Factors underlying such a phenomenon may include the need to overcome cytochrome inhibition, to provide an increased oxygen diffusion gradient to meet cerebral metabolic demands, and/or to ensure adequate CBF to unaffected brain regions or to injured brain in those cases in which no excessive perfusion occurs.
Unfortunately there is no hemodynamic or oxygen transport-related variable that directly reflects the adequacy of the oxygen supply at the tissue and cellular level. Macrocirculatory oxygen transport can be measured, but it is the microcirculation that is the major determinant of tissue oxygen delivery. Only at this level can one assess whether therapeutic interventions actually improve the cellular oxygen supply. Further studies of elevated SjvO 2 as an index of impaired oxygen extraction should help clarify these issues.
